Differentiating Hepatic Perivascular Epithelioid Cell Tumor from Hepatocellular Carcinoma without High-Risk Factors using Contrast-Enhanced Ultrasound Announcing a new article publication for BIO Integration journal. Hepatic perivascular epithelioid cell tumor (PEComa) is a rare tumor with malignant potential that is frequently misdiagnosed as hepat...

Investigating the #imaging characteristics of #PEComa & #HCC without high-risk factors using #CUS and #CUES to improve #preoperative diagnostic accuracy.

#OpenAccess: bio-integration.org/imaging-preo...

Can adding aromatase inhibitor (+/-LHRHa) rescue patients with #PEComa who progress after responding to mTOR inhibitor? #CTOS2025

- n=23 women
- 26% PR, 35% SD
- Time to progression generally shorter than initial mTORi response
- Some exceptions in patients with TSC1/TSC2/PTEN

Most of these signs have many possible causes but if they don’t go away, get checked out. Early diagnosis is key. #PEComa is rare. But people living with it deserve answers, treatment, and support. Don’t ignore strange symptoms. You deserve to be heard.

#KnowYourNormal #SarcomaAwarenessMonth

A graphic featuring sunflowers for PEComa Awareness Day, July 12, 2025. The caption reads: "Fewer than 1 in 1 million people are diagnosed with PEComa each year. It is one of the rarest forms of sarcoma. Sarcoma Awareness Month 2025. awareness.sarcoma-patients.org."

🧬 What is PEComa?
It’s a rare cancer that can form in places like the uterus, lungs, or belly. Because it’s so rare, it’s often overlooked. Here are signs to watch for 🧵
#PEComa #SarcomaAwarenessMonth

1/3